Menopause and colorectal cancer

Area of Science:

• Oncology
• Endocrinology
• Epidemiology

Background:

• Hormone replacement therapy (HRT) is a common intervention for menopausal symptoms.
• The long-term effects of HRT on cancer risk, particularly colorectal cancer, require further investigation.
• Understanding hormonal influences on cancer development in post-menopausal women is crucial.

Purpose of the Study:

• To investigate the association between hormone replacement therapy (HRT) use and the risk of colon cancer in post-menopausal women.
• To compare the risk of colon cancer in post-menopausal women who have never used HRT with that of premenopausal women.
• To explore potential modifying factors such as body composition and hormone levels.

Main Methods:

• Comparative analysis of cancer incidence rates between different menopausal and HRT status groups.
• Stratification of risk based on duration and specific characteristics like lean body mass and oestradiol levels.
• Control for confounding factors including age, socio-cultural class, and dietary habits.

Main Results:

• Post-menopausal women who never used HRT exhibited a significantly higher risk of colon cancer compared to premenopausal women.
• This increased risk was observed specifically for colon cancer, not rectal cancer.
• The elevated risk appeared to persist for approximately 10 years post-menopause and was predominantly seen in lean women with lower oestradiol levels.

Conclusions:

• Nulliparity and never having used hormone replacement therapy (HRT) are associated with an increased risk of colon cancer in post-menopausal women.
• The findings suggest a potential role for endogenous oestradiol levels and body composition in modulating this risk.
• Further research is warranted to elucidate the specific mechanisms linking hormonal status, body type, and colorectal cancer development.